Single-use and reusable needle-free injection devices will be designed for precise self-administration and home use. PharmaJet injector pens are intended for needle-free subcutaneous delivery of a ...

GOLDEN, Colo.--(BUSINESS WIRE)--PharmaJet ®, a company who has developed and commercialized an intradermal needle-free platform to more effectively administer drugs and biologics, today announced that ...

PharmaJet will deliver two presentations on October 27 focusing on current and future applications of their needle-free technology. The Tropis® intradermal (ID) Needle-free Injection System overcomes ...

GOLDEN, Colo.--(BUSINESS WIRE)--PharmaJet ®, the maker of innovative, needle-free injection technology, announced that their latest partnerships and research results will be presented at the World ...

Proprietary technology positioned to become the new standard of care in global drug delivery SANTA CLARA, Calif., Oct. 2, 2018 /PRNewswire/ -- Based on its recent analysis of the global drug delivery ...

The PharmaJet Tropis Intradermal (ID) Needle-free System will be used exclusively to deliver vaccine to 1.8 million children in upcoming campaign. To date, 12+ million pediatric injections have been ...

With one study suggesting needle phobia may account for 10% of COVID-19 vaccine hesitancy, there is potential for alternative delivery routes to clear a barrier to vaccination. Scancell has advanced ...

GOLDEN, Colo. and CAIRO, Oct. 31, 2025 (GLOBE NEWSWIRE) -- PharmaJet ®, a company that strives to improve the performance and outcomes of injectables with its enabling needle-free injection technology ...

The MarketWatch News Department was not involved in the creation of this content. -- Single-use and reusable needle-free injection devices will be designed for precise self-administration and home use ...

The introduction of Tropis into immunization programs supports Egypt’s "1000 Golden Days" initiative which was launched to support the health and development of families during the critical period ...